nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—multiple sclerosis—amyotrophic lateral sclerosis	0.876	1	CtDrD
Prednisone—Personality change—Riluzole—amyotrophic lateral sclerosis	0.00609	0.0615	CcSEcCtD
Prednisone—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0483	CcSEcCtD
Prednisone—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0316	CcSEcCtD
Prednisone—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00284	0.0287	CcSEcCtD
Prednisone—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0248	CcSEcCtD
Prednisone—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.00228	0.023	CcSEcCtD
Prednisone—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00208	0.021	CcSEcCtD
Prednisone—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0184	CcSEcCtD
Prednisone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0167	CcSEcCtD
Prednisone—Mania—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0162	CcSEcCtD
Prednisone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0158	CcSEcCtD
Prednisone—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0157	CcSEcCtD
Prednisone—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0149	CcSEcCtD
Prednisone—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0145	CcSEcCtD
Prednisone—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0143	CcSEcCtD
Prednisone—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0142	CcSEcCtD
Prednisone—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0137	CcSEcCtD
Prednisone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0134	CcSEcCtD
Prednisone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00128	0.013	CcSEcCtD
Prednisone—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0125	CcSEcCtD
Prednisone—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0125	CcSEcCtD
Prednisone—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0125	CcSEcCtD
Prednisone—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0124	CcSEcCtD
Prednisone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0118	CcSEcCtD
Prednisone—HSD11B1—medulla oblongata—amyotrophic lateral sclerosis	0.00114	0.104	CbGeAlD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.00111	0.0807	CbGpPWpGaD
Prednisone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0112	CcSEcCtD
Prednisone—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0107	CcSEcCtD
Prednisone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0105	CcSEcCtD
Prednisone—HSD11B1—spinal cord—amyotrophic lateral sclerosis	0.00102	0.0927	CbGeAlD
Prednisone—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0102	CcSEcCtD
Prednisone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.001	0.0101	CcSEcCtD
Prednisone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000974	0.00984	CcSEcCtD
Prednisone—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.000947	0.00956	CcSEcCtD
Prednisone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000934	0.00943	CcSEcCtD
Prednisone—Injury—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00931	CcSEcCtD
Prednisone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000901	0.00911	CcSEcCtD
Prednisone—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000901	0.00911	CcSEcCtD
Prednisone—Purpura—Riluzole—amyotrophic lateral sclerosis	0.000879	0.00888	CcSEcCtD
Prednisone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000868	0.00877	CcSEcCtD
Prednisone—HSD11B1—nervous system—amyotrophic lateral sclerosis	0.000857	0.0781	CbGeAlD
Prednisone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000847	0.00856	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000847	0.00856	CcSEcCtD
Prednisone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00842	CcSEcCtD
Prednisone—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000827	0.00836	CcSEcCtD
Prednisone—HSD11B1—central nervous system—amyotrophic lateral sclerosis	0.000825	0.0752	CbGeAlD
Prednisone—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000818	0.00826	CcSEcCtD
Prednisone—HSD11B1—cerebellum—amyotrophic lateral sclerosis	0.000807	0.0735	CbGeAlD
Prednisone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00814	CcSEcCtD
Prednisone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000802	0.0081	CcSEcCtD
Prednisone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000771	0.00779	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000747	0.00755	CcSEcCtD
Prednisone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000747	0.00755	CcSEcCtD
Prednisone—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00744	CcSEcCtD
Prednisone—NR3C1—nerve—amyotrophic lateral sclerosis	0.000721	0.0657	CbGeAlD
Prednisone—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000718	0.00725	CcSEcCtD
Prednisone—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000684	0.00691	CcSEcCtD
Prednisone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000674	0.00681	CcSEcCtD
Prednisone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00673	CcSEcCtD
Prednisone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000662	0.00669	CcSEcCtD
Prednisone—HSD11B1—brain—amyotrophic lateral sclerosis	0.000655	0.0597	CbGeAlD
Prednisone—Depression—Riluzole—amyotrophic lateral sclerosis	0.000651	0.00657	CcSEcCtD
Prednisone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000643	0.0065	CcSEcCtD
Prednisone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00064	0.00646	CcSEcCtD
Prednisone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00064	0.00646	CcSEcCtD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000625	0.0455	CbGpPWpGaD
Prednisone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000596	0.00603	CcSEcCtD
Prednisone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000589	0.00595	CcSEcCtD
Prednisone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000586	0.00592	CcSEcCtD
Prednisone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00589	CcSEcCtD
Prednisone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00582	CcSEcCtD
Prednisone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000548	0.00553	CcSEcCtD
Prednisone—NR3C1—hindbrain—amyotrophic lateral sclerosis	0.00054	0.0492	CbGeAlD
Prednisone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000532	0.00537	CcSEcCtD
Prednisone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00535	CcSEcCtD
Prednisone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000523	0.00529	CcSEcCtD
Prednisone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00523	CcSEcCtD
Prednisone—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000513	0.00519	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000513	0.0374	CbGpPWpGaD
Prednisone—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00051	0.00515	CcSEcCtD
Prednisone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000473	0.00478	CcSEcCtD
Prednisone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00476	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000469	0.0342	CbGpPWpGaD
Prednisone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00473	CcSEcCtD
Prednisone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00471	CcSEcCtD
Prednisone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00046	0.00465	CcSEcCtD
Prednisone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00463	CcSEcCtD
Prednisone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000457	0.00462	CcSEcCtD
Prednisone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00453	CcSEcCtD
Prednisone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00446	CcSEcCtD
Prednisone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00044	0.00445	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000436	0.0318	CbGpPWpGaD
Prednisone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00439	CcSEcCtD
Prednisone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00439	CcSEcCtD
Prednisone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000433	0.00437	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000431	0.00436	CcSEcCtD
Prednisone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000429	0.00433	CcSEcCtD
Prednisone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000416	0.00421	CcSEcCtD
Prednisone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000416	0.00421	CcSEcCtD
Prednisone—Infection—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00418	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00041	0.0299	CbGpPWpGaD
Prednisone—Shock—Riluzole—amyotrophic lateral sclerosis	0.00041	0.00414	CcSEcCtD
Prednisone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00412	CcSEcCtD
Prednisone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000406	0.0041	CcSEcCtD
Prednisone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000404	0.00408	CcSEcCtD
Prednisone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000402	0.00407	CcSEcCtD
Prednisone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00401	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000379	0.00383	CcSEcCtD
Prednisone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000376	0.0038	CcSEcCtD
Prednisone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00378	CcSEcCtD
Prednisone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000366	0.0037	CcSEcCtD
Prednisone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000362	0.00366	CcSEcCtD
Prednisone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000359	0.00363	CcSEcCtD
Prednisone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000356	0.0036	CcSEcCtD
Prednisone—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.000345	0.0314	CbGeAlD
Prednisone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000343	0.00347	CcSEcCtD
Prednisone—NR3C1—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.000341	0.0248	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00344	CcSEcCtD
Prednisone—NR3C1—embryo—amyotrophic lateral sclerosis	0.000338	0.0308	CbGeAlD
Prednisone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00334	CcSEcCtD
Prednisone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00332	CcSEcCtD
Prednisone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00332	CcSEcCtD
Prednisone—NR3C1—brainstem—amyotrophic lateral sclerosis	0.00031	0.0282	CbGeAlD
Prednisone—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.000308	0.028	CbGeAlD
Prednisone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000307	0.0031	CcSEcCtD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—amyotrophic lateral sclerosis	0.000302	0.022	CbGpPWpGaD
Prednisone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000299	0.00302	CcSEcCtD
Prednisone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000295	0.00298	CcSEcCtD
Prednisone—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000286	0.0208	CbGpPWpGaD
Prednisone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000285	0.00288	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000281	0.0205	CbGpPWpGaD
Prednisone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000275	0.00278	CcSEcCtD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.000269	0.0196	CbGpPWpGaD
Prednisone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000265	0.00267	CcSEcCtD
Prednisone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000262	0.00265	CcSEcCtD
Prednisone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000262	0.00265	CcSEcCtD
Prednisone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00263	CcSEcCtD
Prednisone—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.000259	0.0236	CbGeAlD
Prednisone—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.00025	0.0227	CbGeAlD
Prednisone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000247	0.0025	CcSEcCtD
Prednisone—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.000244	0.0222	CbGeAlD
Prednisone—HSD11B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000229	0.0166	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000229	0.0166	CbGpPWpGaD
Prednisone—NR3C1—medulla oblongata—amyotrophic lateral sclerosis	0.000216	0.0197	CbGeAlD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000213	0.0155	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000209	0.0152	CbGpPWpGaD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0002	0.0146	CbGpPWpGaD
Prednisone—SLCO1A2—brain—amyotrophic lateral sclerosis	0.000198	0.0181	CbGeAlD
Prednisone—ALB—brain—amyotrophic lateral sclerosis	0.000197	0.0179	CbGeAlD
Prednisone—HSD11B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000194	0.0142	CbGpPWpGaD
Prednisone—NR3C1—spinal cord—amyotrophic lateral sclerosis	0.000193	0.0175	CbGeAlD
Prednisone—HSD11B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000183	0.0133	CbGpPWpGaD
Prednisone—ABCB1—embryo—amyotrophic lateral sclerosis	0.000181	0.0165	CbGeAlD
Prednisone—HSD11B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000165	0.012	CbGpPWpGaD
Prednisone—NR3C1—nervous system—amyotrophic lateral sclerosis	0.000162	0.0148	CbGeAlD
Prednisone—NR3C1—central nervous system—amyotrophic lateral sclerosis	0.000156	0.0142	CbGeAlD
Prednisone—NR3C1—cerebellum—amyotrophic lateral sclerosis	0.000153	0.0139	CbGeAlD
Prednisone—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.000141	0.0103	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000135	0.00984	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000127	0.00928	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000125	0.00912	CbGpPWpGaD
Prednisone—NR3C1—brain—amyotrophic lateral sclerosis	0.000124	0.0113	CbGeAlD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000123	0.00898	CbGpPWpGaD
Prednisone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000123	0.0112	CbGeAlD
Prednisone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000118	0.0108	CbGeAlD
Prednisone—NR3C1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000117	0.00851	CbGpPWpGaD
Prednisone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000116	0.0105	CbGeAlD
Prednisone—HSD11B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000116	0.00842	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.000115	0.00839	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00011	0.008	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.00767	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000104	0.00756	CbGpPWpGaD
Prednisone—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000103	0.00939	CbGeAlD
Prednisone—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000103	0.00749	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	9.88e-05	0.0072	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.49e-05	0.00691	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.34e-05	0.00681	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	8.86e-05	0.00645	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	8.71e-05	0.00634	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	8.71e-05	0.00634	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	8.71e-05	0.00634	CbGpPWpGaD
Prednisone—ABCB1—nervous system—amyotrophic lateral sclerosis	8.69e-05	0.00791	CbGeAlD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.66e-05	0.00631	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.55e-05	0.00623	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	8.54e-05	0.00622	CbGpPWpGaD
Prednisone—ABCB1—central nervous system—amyotrophic lateral sclerosis	8.36e-05	0.00762	CbGeAlD
Prednisone—ABCB1—cerebellum—amyotrophic lateral sclerosis	8.17e-05	0.00745	CbGeAlD
Prednisone—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	8.11e-05	0.00591	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.95e-05	0.00579	CbGpPWpGaD
Prednisone—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.48e-05	0.00545	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.47e-05	0.00544	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	7.26e-05	0.00529	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	7.19e-05	0.00524	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	6.73e-05	0.0049	CbGpPWpGaD
Prednisone—ABCB1—brain—amyotrophic lateral sclerosis	6.64e-05	0.00605	CbGeAlD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	6.47e-05	0.00471	CbGpPWpGaD
Prednisone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	6.32e-05	0.0046	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	6.17e-05	0.0045	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.93e-05	0.00432	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.88e-05	0.00428	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	5.85e-05	0.00426	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	5.63e-05	0.0041	CbGpPWpGaD
Prednisone—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	5.39e-05	0.00393	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.32e-05	0.00388	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	5.31e-05	0.00386	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.12e-05	0.00373	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	5.11e-05	0.00372	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.1e-05	0.00371	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	5.03e-05	0.00367	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	5.02e-05	0.00365	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	4.95e-05	0.0036	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SMN1—amyotrophic lateral sclerosis	4.78e-05	0.00349	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	4.78e-05	0.00348	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.69e-05	0.00341	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	4.65e-05	0.00339	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	4.65e-05	0.00338	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	4.6e-05	0.00335	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.57e-05	0.00333	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	4.5e-05	0.00328	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.34e-05	0.00316	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	4.26e-05	0.00311	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.18e-05	0.00304	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	4.17e-05	0.00304	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.16e-05	0.00303	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.16e-05	0.00303	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.1e-05	0.00299	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	4.04e-05	0.00294	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	3.98e-05	0.0029	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.88e-05	0.00283	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.88e-05	0.00283	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—APOE—amyotrophic lateral sclerosis	3.86e-05	0.00281	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.81e-05	0.00277	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	3.8e-05	0.00277	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.75e-05	0.00273	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.69e-05	0.00269	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.69e-05	0.00269	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.65e-05	0.00266	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	3.55e-05	0.00258	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.54e-05	0.00258	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	3.52e-05	0.00256	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.48e-05	0.00254	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.46e-05	0.00252	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IGF1—amyotrophic lateral sclerosis	3.38e-05	0.00246	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	3.36e-05	0.00245	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.33e-05	0.00242	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.32e-05	0.00242	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.29e-05	0.0024	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.29e-05	0.0024	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.28e-05	0.00239	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.2e-05	0.00233	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	3.16e-05	0.0023	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.16e-05	0.0023	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	3.06e-05	0.00223	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.01e-05	0.00219	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	2.96e-05	0.00215	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	2.91e-05	0.00212	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.88e-05	0.0021	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—FUS—amyotrophic lateral sclerosis	2.75e-05	0.002	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	2.74e-05	0.002	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	2.66e-05	0.00194	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.64e-05	0.00192	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	2.63e-05	0.00192	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.5e-05	0.00182	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	2.45e-05	0.00178	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.44e-05	0.00178	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	2.41e-05	0.00176	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.38e-05	0.00174	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	2.37e-05	0.00173	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	2.35e-05	0.00171	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.35e-05	0.00171	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.28e-05	0.00166	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	2.25e-05	0.00164	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.25e-05	0.00164	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—RARA—amyotrophic lateral sclerosis	2.24e-05	0.00163	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	2.22e-05	0.00162	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.12e-05	0.00154	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.1e-05	0.00153	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.08e-05	0.00152	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.06e-05	0.0015	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.04e-05	0.00149	CbGpPWpGaD
Prednisone—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	2.03e-05	0.00148	CbGpPWpGaD
Prednisone—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	2.03e-05	0.00148	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	2e-05	0.00146	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	2e-05	0.00145	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.96e-05	0.00143	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.0014	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	1.91e-05	0.00139	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	1.9e-05	0.00139	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.9e-05	0.00138	CbGpPWpGaD
Prednisone—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	1.86e-05	0.00135	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.86e-05	0.00135	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.83e-05	0.00133	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.83e-05	0.00133	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.8e-05	0.00131	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.8e-05	0.00131	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.78e-05	0.0013	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.78e-05	0.0013	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.77e-05	0.00129	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	1.76e-05	0.00128	CbGpPWpGaD
Prednisone—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.73e-05	0.00126	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.73e-05	0.00126	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.7e-05	0.00124	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.67e-05	0.00122	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.63e-05	0.00119	CbGpPWpGaD
Prednisone—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	1.63e-05	0.00118	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.61e-05	0.00117	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.58e-05	0.00115	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.58e-05	0.00115	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.58e-05	0.00115	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.55e-05	0.00113	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.51e-05	0.0011	CbGpPWpGaD
Prednisone—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	1.47e-05	0.00107	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.46e-05	0.00106	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.43e-05	0.00104	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.42e-05	0.00104	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.41e-05	0.00103	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.41e-05	0.00103	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	1.36e-05	0.000988	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.34e-05	0.000973	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.32e-05	0.000961	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.29e-05	0.000938	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	1.15e-05	0.000835	CbGpPWpGaD
Prednisone—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	1.11e-05	0.000811	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.11e-05	0.000807	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.1e-05	0.0008	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.1e-05	0.0008	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.08e-05	0.000787	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	0.000749	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.03e-05	0.000749	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	1.03e-05	0.000749	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1e-05	0.000731	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1e-05	0.000728	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.76e-06	0.000711	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.36e-06	0.000682	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.33e-06	0.00068	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.29e-06	0.000677	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	9.23e-06	0.000672	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	9.01e-06	0.000656	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	8.86e-06	0.000645	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.77e-06	0.000639	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.72e-06	0.000636	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.53e-06	0.000622	CbGpPWpGaD
Prednisone—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	8.44e-06	0.000615	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.41e-06	0.000612	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.94e-06	0.000578	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.7e-06	0.000561	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	7.58e-06	0.000552	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.4e-06	0.000539	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	7.02e-06	0.000511	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	6.99e-06	0.000509	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.92e-06	0.000504	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.59e-06	0.00048	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.01e-06	0.000438	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.55e-06	0.000404	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.28e-06	0.000385	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.81e-06	0.00035	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.74e-06	0.000345	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.57e-06	0.000333	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.56e-06	0.000332	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.54e-06	0.000331	CbGpPWpGaD
Prednisone—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.17e-06	0.000304	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.07e-06	0.000297	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.98e-06	0.00029	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.74e-06	0.000273	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.65e-06	0.000266	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	3.45e-06	0.000251	CbGpPWpGaD
Prednisone—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	3.43e-06	0.00025	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.08e-06	0.000224	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.01e-06	0.000219	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.45e-06	0.000178	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.35e-06	0.000171	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.25e-06	0.000164	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-06	0.000154	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.06e-06	0.00015	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.85e-06	0.000135	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.27e-06	9.24e-05	CbGpPWpGaD
